Inventor · disambiguated record
Susan Faas Mcknight
Also filed as: FAAS MCKNIGHT SUSAN
8 granted patents·3 pending applications·101 citations·filing 2007–2014
88Inventor score
Top patents by PatentIndex Score
11 records- 0194US8075884B2Antibodies to OX-2/CD200 and uses thereofBOWDISH KATHERINE S·Filed 2007·Granted Dec 13, 2011·41 cites·26 claims
- 0293US8709415B2Antibodies to OX-2/CD200 and uses thereofBOWDISH KATHERINE S·Filed 2011·Granted Apr 29, 2014·24 cites·42 claims
- 0387US8252285B2Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responsesROTHER RUSSELL P·Filed 2008·Granted Aug 28, 2012·8 cites·30 claims
- 0485US9000133B2Antibodies to OX-2/CD200 and uses thereofALEXION PHARMA INC·Filed 2013·Granted Apr 7, 2015·6 cites·30 claims
- 0585US8637014B2Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responsesROTHER RUSSELL P·Filed 2012·Granted Jan 28, 2014·7 cites·29 claims
- 0681USRE46323EAntibodies to OX-2/CD200 and uses thereof in inhibiting immune responsesALEXION PHARMA INC·Filed 2008·Granted Feb 28, 2017·3 cites·40 claims
- 0779US9180186B2Biomarkers of immunomodulatory effects in humans treated with anti-CD200 antibodiesFAAS MCKNIGHT SUSAN·Filed 2011·Granted Nov 10, 2015·8 cites·24 claims
- 0874US9447187B2Use of an anti-CD200 antibody for prolonging the survival of allograftsWANG YI·Filed 2012·Granted Sep 20, 2016·4 cites·23 claims
- 0964US2014286962A1Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disordersALEXION PHARMA INC·Filed 2014·Application pending·0 cites
- 1047US2013045192A1Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disordersALEXION PHARMA INC·Filed 2010·Application pending·0 cites
- 1147US2008152648A1Compositions and methods for enhancing an adjuvantALEXION PHARMA INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susan Faas Mcknight files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →